Furthermore, an earlier study by Kusharyanti et al. [31] reported that the combination of hesperidin and doxorubicin in HeLa cervical cancer cells resulted in significant downregulation of Bcl-2, reinforcing the synergy in apoptosis induction. This evidence concerns the gene BCL2 and cervical carcinoma.